+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
DNA Diagnostics Market - Global Forecast to 2030- Product Image
DNA Diagnostics Market - Global Forecast to 2030- Product Image
New

DNA Diagnostics Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6084188
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The DNA Diagnostics Market grew from USD 12.40 billion in 2024 to USD 13.59 billion in 2025. It is expected to continue growing at a CAGR of 9.29%, reaching USD 21.14 billion by 2030.

The field of DNA diagnostics has emerged as a cornerstone of modern healthcare, reshaping approaches to disease detection, personalized medicine, and public health surveillance. Rapid advances in genomic technologies have enabled clinicians and researchers to interrogate genetic material with unprecedented precision, driving innovation from early disease screening to targeted therapeutic interventions. This executive summary offers a concise yet comprehensive overview of the current state of DNA diagnostics, highlighting the forces that have propelled its evolution and the challenges that lie ahead. As we delve into the transformative technological breakthroughs, regulatory dynamics, and market drivers, readers will gain a clear understanding of how DNA diagnostics is poised to influence clinical decision-making and improve patient outcomes globally. Transitioning seamlessly from foundational concepts to emerging trends, this introduction sets the stage for an in-depth exploration of the strategic shifts, segmentation nuances, regional dynamics, and competitive landscape that define today’s DNA diagnostics market.

Transformative Shifts Shaping DNA Diagnostics

Over the past decade, DNA diagnostics has undergone several paradigm shifts that have redefined its clinical and commercial trajectories. Next-generation sequencing has transitioned from a research-only tool to a frontline diagnostic platform, enabling high-throughput analysis of entire genomes at dramatically reduced costs. Simultaneously, digital PCR and real-time PCR have matured into indispensable methods for ultra-sensitive mutation detection and quantification. Beyond instrumentation, the integration of cloud-based data analysis and artificial intelligence has accelerated variant interpretation, reducing turnaround times and enhancing diagnostic accuracy. Concurrently, regulatory agencies worldwide have adopted more streamlined approval pathways for in vitro diagnostics, fostering faster market entry for novel assays. Public-private partnerships and increased government funding for precision medicine initiatives have further catalyzed innovation, while heightened awareness of antimicrobial resistance has intensified demand for rapid infectious disease testing solutions. These transformative shifts underscore the dynamic interplay between technological innovation, policy evolution, and clinical necessity that continues to shape the DNA diagnostics landscape.

Assessing the 2025 U.S. Tariff Impact on DNA Diagnostics

In 2025, the implementation of revised U.S. tariffs on imported diagnostic reagents, instruments, and consumables has had a cumulative impact on the DNA diagnostics ecosystem. Supply chains experienced increased lead times and cost pressures as manufacturers adjusted sourcing strategies to mitigate tariff burdens on key inputs, from specialized enzymes to microarray substrates. In response, many global instrument providers localized production of sequencers, PCR systems, and ancillary components, seeking tariff exemptions under free trade agreements and investing in domestic manufacturing capabilities. Diagnostic laboratories have absorbed portions of the additional costs through operational efficiencies and strategic vendor negotiations, but some higher-cost tests have seen modest reimbursements adjustments to reflect elevated overheads. Meanwhile, reagent suppliers have optimized formulation and packaging to maintain price competitiveness, leveraging bulk procurement and lean inventory management. Although the tariff environment introduced short-term pricing volatility, it also accelerated regional diversification of supply networks and encouraged stronger collaboration between instrument makers and reagent producers to ensure continuity of testing services across the United States.

Segmentation Insights Driving Market Differentiation

Detailed segmentation of the DNA diagnostics market reveals distinct value pools and innovation opportunities across multiple dimensions. Technological segmentation explores microarray platforms such as gene expression profiling and SNP genotyping, next-generation sequencing tools including those offered by Illumina, Roche and Thermo Fisher, and polymerase chain reaction systems spanning digital PCR, real-time PCR and traditional PCR formats. Application segmentation highlights genetic testing services ranging from carrier testing and newborn screening to predictive and presymptomatic assessments as well as prenatal diagnostics; infectious disease testing capabilities that emphasize pathogen identification and viral load quantification; oncology diagnostics incorporating both multi-gene panels and single-gene assays; and transplantation diagnostics that focus on histocompatibility evaluation and organ acceptance monitoring. End-user segmentation underscores the roles of academic and research institutions, which span independent research organizations and university-affiliated centers, alongside diagnostic laboratories differentiated into clinical and research laboratories, and hospitals and clinics encompassing inpatient wards and outpatient departments. Product and service segmentation identifies instruments and analyzers-comprising microarrays, PCR systems and sequencers-alongside reagents and consumables such as kits, assays, probes and primers, and an expanding suite of software and services including consulting and advanced data analysis solutions. Sample-type segmentation examines blood specimens, both plasma and whole blood; saliva samples collected via oral swab or spit collection; and tissue materials sourced from biopsy samples and surgical specimens. These segmentation insights illuminate growth drivers, unmet clinical needs and potential white spaces for technology developers and service providers alike.

Regional Dynamics and Growth Opportunities

Regional analysis of the DNA diagnostics market reveals unique drivers and challenges in each geography. In the Americas, strong reimbursement frameworks, established clinical genomics infrastructure and growing demand for personalized oncology and infectious disease testing underpin sustained market expansion. Conversely, Europe, Middle East & Africa regions display heterogeneous adoption rates, where robust public health initiatives in Western Europe contrast with emerging diagnostic needs in the Middle East and Africa, prompting investments in mobile testing units and point-of-care platforms. In the Asia-Pacific region, rapid urbanization, increasing healthcare expenditure and expanded newborn screening programs fuel uptake of both high-throughput sequencing and automated PCR solutions; however, regulatory harmonization and supply chain resilience remain critical focus areas. Cross-regional collaborations, including technology transfer agreements and multicenter clinical studies, are facilitating knowledge exchange and accelerating local market penetration. Understanding these regional dynamics is essential for companies seeking to tailor market entry strategies, align commercial models with reimbursement policies and forge partnerships that address specific healthcare system priorities.

Key Competitive Landscape and Company Profiles

The competitive DNA diagnostics landscape features a blend of global conglomerates, specialized testing laboratories and agile innovators. Abbott Laboratories and Adaptive Biotechnologies lead advancements in immune-profiling and sequencing assays, while Agilent Technologies, Inc. and ARUP Laboratories excel in precision microarray solutions and high-complexity testing services. Becton, Dickinson and Company and Bio-Rad Laboratories, Inc. offer robust PCR systems paired with proprietary reagents, and BioMérieux and Danaher Corporation deliver integrated platforms that streamline infectious disease workflows. DNA Diagnostic A/S and Eurofins have built reputations on scalable genomic screening services, whereas Exact Sciences Corporation and F. Hoffmann-La Roche Ltd. focus on oncology diagnostics with advanced liquid biopsy and companion diagnostics offerings. Hologic, Inc. and Illumina, Inc. continue to push the envelope in sequencing throughput and automated sample processing, complemented by Invitae Corporation and Laboratory Corporation of America Holdings in comprehensive genetic testing portfolios. Luminex Corporation and Myriad Genetics bring multiplexing and hereditary cancer testing expertise to the market, while Natera, Inc. and Oxford Nanopore Technologies PLC innovate in noninvasive prenatal testing and portable sequencing, respectively. Promega Corporation and QIAGEN GmbH support assay development through reagent kits and molecular sample prep, while Quest Diagnostics and Siemens Healthineers dominate clinical laboratory and diagnostic instrument segments. Sysmex Corporation and Thermo Fisher Scientific Inc. underpin customer success with end-to-end solutions spanning sample collection, analysis and data management. Emerging players such as Veracyte, Inc. further differentiate through novel diagnostic markers and AI-driven interpretation tools. This diverse competitive ecosystem underscores the importance of strategic partnerships, continuous R&D investment and agile commercialization pathways.

Strategic Recommendations for Industry Leaders

To thrive in the evolving DNA diagnostics environment, industry leaders must pursue a multi-pronged strategy. First, forging strategic alliances across technology providers, reagent suppliers and clinical networks will ensure seamless integration of platforms and expedite market access. Second, targeted investments in data analytics and machine learning will enhance assay interpretation, enabling faster, more accurate clinical insights and driving adoption by healthcare professionals. Third, companies should establish flexible manufacturing footprints, balancing domestic production with global supply sources to mitigate geopolitical risks associated with tariff fluctuations and trade disruptions. Fourth, regulatory intelligence teams must engage proactively with agencies to navigate evolving approval pathways and secure expedited clearances for breakthrough diagnostics. Fifth, focusing on end-to-end customer experiences-encompassing training, technical support and outcome-driven value demonstration-will differentiate offerings in a crowded market. Finally, exploring adjacencies such as digital health platforms and telemedicine integrations can create new revenue streams and reinforce diagnostic ecosystems. By executing these actionable recommendations, organizations can position themselves at the forefront of DNA diagnostics innovation and drive long-term sustainable growth.

Conclusion: Navigating the Future of DNA Diagnostics

The DNA diagnostics market stands at a pivotal juncture, where technological innovation, regulatory evolution and shifting clinical demands converge to create both challenges and opportunities. As next-generation sequencing scales into routine care, PCR assays achieve unprecedented sensitivity and data analytics transform raw genomic information into actionable insights, stakeholders must remain agile and collaborative. Embracing a segmentation-driven approach will reveal tailored value propositions for diverse applications and end users, while regional adaptations will unlock growth in emerging healthcare markets. Companies that invest in resilient supply chains and proactive regulatory engagement will mitigate external risks, and those that deliver cohesive end-to-end solutions will capture enduring customer loyalty. Ultimately, the ability to anticipate clinical needs, leverage cross-industry partnerships and maintain a relentless focus on quality and compliance will determine success in this dynamic landscape. With a clear roadmap and the right strategic imperatives in place, the future of DNA diagnostics promises to deliver profound benefits for patients, providers and the broader healthcare ecosystem.

Market Segmentation & Coverage

This research report categorizes the DNA Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Microarray
    • Gene Expression Profiling
    • SNP Genotyping
  • Next-Generation Sequencing
    • Illumina
    • Roche
    • Thermo Fisher
  • Polymerase Chain Reaction
    • Digital PCR
    • Real-Time PCR
    • Traditional PCR
  • Genetic Testing
    • Carrier Testing
    • Newborn Screening
    • Predictive And Presymptomatic Testing
    • Prenatal Testing
  • Infectious Disease Testing
    • Pathogen Identification
    • Viral Load Testing
  • Oncology Diagnostics
    • Multi-Gene Testing
    • Single-Gene Testing
  • Transplantation Diagnostics
    • Histocompatibility Testing
    • Organ Acceptance Monitoring
  • Academic And Research Institutions
    • Independent Research Organizations
    • University Research Centers
  • Diagnostic Laboratories
    • Clinical Laboratories
    • Research Laboratories
  • Hospitals And Clinics
    • Inpatient Facilities
    • Outpatient Departments
  • Instruments And Analyzers
    • Microarrays
    • PCR Systems
    • Sequencers
  • Reagents And Consumables
    • Kits And Assays
    • Probes And Primers
  • Software And Services
    • Consulting Services
    • Data Analysis Software
  • Blood
    • Plasma
    • Whole Blood
  • Saliva
    • Oral Swab
    • Spit Collection
  • Tissue
    • Biopsy Samples
    • Surgical Specimens

This research report categorizes the DNA Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the DNA Diagnostics Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • Adaptive Biotechnologies
  • Agilent Technologies, Inc.
  • ARUP Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMérieux
  • Danaher Corporation
  • DNA Diagnostic A/S
  • Eurofins
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Myriad Genetics
  • Natera, Inc.
  • Oxford Nanopore Technologies PLC
  • Promega Corporation
  • QIAGEN GmbH
  • Quest Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. DNA Diagnostics Market, by Technology Type
8.1. Introduction
8.2. Microarray
8.2.1. Gene Expression Profiling
8.2.2. SNP Genotyping
8.3. Next-Generation Sequencing
8.3.1. Illumina
8.3.2. Roche
8.3.3. Thermo Fisher
8.4. Polymerase Chain Reaction
8.4.1. Digital PCR
8.4.2. Real-Time PCR
8.4.3. Traditional PCR
9. DNA Diagnostics Market, by Application
9.1. Introduction
9.2. Genetic Testing
9.2.1. Carrier Testing
9.2.2. Newborn Screening
9.2.3. Predictive And Presymptomatic Testing
9.2.4. Prenatal Testing
9.3. Infectious Disease Testing
9.3.1. Pathogen Identification
9.3.2. Viral Load Testing
9.4. Oncology Diagnostics
9.4.1. Multi-Gene Testing
9.4.2. Single-Gene Testing
9.5. Transplantation Diagnostics
9.5.1. Histocompatibility Testing
9.5.2. Organ Acceptance Monitoring
10. DNA Diagnostics Market, by End User
10.1. Introduction
10.2. Academic And Research Institutions
10.2.1. Independent Research Organizations
10.2.2. University Research Centers
10.3. Diagnostic Laboratories
10.3.1. Clinical Laboratories
10.3.2. Research Laboratories
10.4. Hospitals And Clinics
10.4.1. Inpatient Facilities
10.4.2. Outpatient Departments
11. DNA Diagnostics Market, by Product And Service
11.1. Introduction
11.2. Instruments And Analyzers
11.2.1. Microarrays
11.2.2. PCR Systems
11.2.3. Sequencers
11.3. Reagents And Consumables
11.3.1. Kits And Assays
11.3.2. Probes And Primers
11.4. Software And Services
11.4.1. Consulting Services
11.4.2. Data Analysis Software
12. DNA Diagnostics Market, by Sample Type
12.1. Introduction
12.2. Blood
12.2.1. Plasma
12.2.2. Whole Blood
12.3. Saliva
12.3.1. Oral Swab
12.3.2. Spit Collection
12.4. Tissue
12.4.1. Biopsy Samples
12.4.2. Surgical Specimens
13. Americas DNA Diagnostics Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific DNA Diagnostics Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa DNA Diagnostics Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Adaptive Biotechnologies
16.3.3. Agilent Technologies, Inc.
16.3.4. ARUP Laboratories
16.3.5. Becton, Dickinson and Company
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. BioMérieux
16.3.8. Danaher Corporation
16.3.9. DNA Diagnostic A/S
16.3.10. Eurofins
16.3.11. Exact Sciences Corporation
16.3.12. F. Hoffmann-La Roche Ltd.
16.3.13. Hologic, Inc.
16.3.14. Illumina, Inc.
16.3.15. Invitae Corporation
16.3.16. Laboratory Corporation of America Holdings
16.3.17. Luminex Corporation
16.3.18. Myriad Genetics
16.3.19. Natera, Inc.
16.3.20. Oxford Nanopore Technologies PLC
16.3.21. Promega Corporation
16.3.22. QIAGEN GmbH
16.3.23. Quest Diagnostics
16.3.24. Siemens Healthineers
16.3.25. Sysmex Corporation
16.3.26. Thermo Fisher Scientific Inc.
16.3.27. Veracyte, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DNA DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. DNA DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. DNA DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DNA DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DNA DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DNA DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DNA DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DNA DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SNP GENOTYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY ILLUMINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY ROCHE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY THERMO FISHER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PREDICTIVE AND PRESYMPTOMATIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PATHOGEN IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY VIRAL LOAD TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY MULTI-GENE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SINGLE-GENE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY HISTOCOMPATIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY ORGAN ACCEPTANCE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY INDEPENDENT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY UNIVERSITY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY INPATIENT FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY OUTPATIENT DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY KITS AND ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PROBES AND PRIMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY ORAL SWAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SPIT COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY BIOPSY SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY SURGICAL SPECIMENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 144. CANADA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 145. CANADA DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 146. CANADA DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 147. CANADA DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 148. CANADA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. CANADA DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 150. CANADA DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 151. CANADA DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 152. CANADA DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 153. CANADA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. CANADA DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 155. CANADA DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 156. CANADA DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 157. CANADA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 158. CANADA DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 159. CANADA DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 160. CANADA DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 161. CANADA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 162. CANADA DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 163. CANADA DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 164. CANADA DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 165. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 166. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 167. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 168. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 169. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 171. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 172. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 173. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 174. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 177. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 179. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 180. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 181. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 182. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 183. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 184. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 185. MEXICO DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES DNA DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC DNA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 251. CHINA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 252. CHINA DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 253. CHINA DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 254. CHINA DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 255. CHINA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. CHINA DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 257. CHINA DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 258. CHINA DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 259. CHINA DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 260. CHINA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. CHINA DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 262. CHINA DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 263. CHINA DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 264. CHINA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 265. CHINA DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 266. CHINA DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 267. CHINA DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 268. CHINA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 269. CHINA DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 270. CHINA DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 271. CHINA DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 272. INDIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 273. INDIA DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 274. INDIA DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 275. INDIA DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 276. INDIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. INDIA DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 278. INDIA DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 279. INDIA DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 280. INDIA DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 281. INDIA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. INDIA DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 283. INDIA DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 284. INDIA DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 285. INDIA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 286. INDIA DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 287. INDIA DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 288. INDIA DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 289. INDIA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 290. INDIA DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 291. INDIA DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 292. INDIA DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 293. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 294. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 295. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 296. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 297. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 299. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 300. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 301. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 302. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 304. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 305. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 306. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 307. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 308. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 309. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 314. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 315. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 316. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 317. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 318. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 320. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 321. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 322. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY TRANSPLANTATION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 323. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 325. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 326. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 327. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2018-2030 (USD MILLION)
TABLE 328. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 329. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 330. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 331. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 332. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 333. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 334. JAPAN DNA DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA DNA DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 341. MALAYSI

Companies Mentioned

  • Abbott Laboratories
  • Adaptive Biotechnologies
  • Agilent Technologies, Inc.
  • ARUP Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMérieux
  • Danaher Corporation
  • DNA Diagnostic A/S
  • Eurofins
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Myriad Genetics
  • Natera, Inc.
  • Oxford Nanopore Technologies PLC
  • Promega Corporation
  • QIAGEN GmbH
  • Quest Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

DNA Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR-based Diagnostics, NGS DNA Diagnosis), By Application (Cancer Genetics Tests, Infectious Diseases DNA Testing), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

DNA Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR-based Diagnostics, NGS DNA Diagnosis), By Application (Cancer Genetics Tests, Infectious Diseases DNA Testing), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Forecast to 2029 - Product Image

DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Forecast to 2029

  • Report
  • 334 Pages
  • Global
From
DNA Diagnostics Market - Global Outlook & Forecast 2025-2030 - Product Image

DNA Diagnostics Market - Global Outlook & Forecast 2025-2030

  • Report
  • 429 Pages
  • Global
From
DNA Diagnostics Market Report 2025 - Product Image

DNA Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.